Kavuru Vimal
Insider CIK 1697184 · ACST Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GRCE Grace Therapeutics, Inc. | A Award deriv | 2026-09-17 | 2026-09-21 | 12,200 | — | $0 | 12,200 | SEC↗ |
| GRCE Grace Therapeutics, Inc. | A Award deriv | 2026-09-17 | 2026-09-21 | 12,200 | — | $0 | 12,200 | SEC↗ |
| GRCE Grace Therapeutics, Inc. | A Award deriv | 2026-01-08 | 2026-01-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GRCE Grace Therapeutics, Inc. | A Award deriv | 2025-05-09 | 2025-05-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACST Acasti Pharma Inc. | A Award deriv | 2023-12-19 | 2023-12-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACST Acasti Pharma Inc. | P Buy deriv | 2023-09-25 | 2023-09-27 | 422,732 | $0.13 | $55.0K | 422,732 | SEC↗ |
| ACST Acasti Pharma Inc. | P Buy | 2023-09-25 | 2023-09-27 | 676,371 | $1.85 | $1.25M | 1,188,076 | SEC↗ |
| ACST Acasti Pharma Inc. | A Award deriv | 2023-07-14 | 2023-07-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ACST Acasti Pharma Inc. | A Award deriv | 2022-09-28 | 2022-09-30 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ACST Acasti Pharma Inc. | A Award deriv | 2021-11-12 | 2021-11-16 | 42,100 | — | $0 | 42,100 | SEC↗ |